Upper GI 2016
PRE-OPERATIVE treatments improve OS
N population
Type
mOS (months)
3-year Survival (%)
Kelsen, 1998
440 46% SCC 54% ADC 802 31% SCC 69% adc
Surg +/- CT
14.9 vs 16.1
26 vs 23
MRC, 2002 Allumet, 2009
Surg +/- CT
13.3 vs 16.8
17 vs 23 (5 yrs)
✔
Cunningham,
503 74%adc gastr
Surg +/-
NR
23 vs 36
✔
Chimiothérapie Préopératoire
2006
26%adc oeso CT p rio ératoire
(5 yrs)
Le Prise, 1994
86 100% SCC
Surg +/- RTCT
10.0 vs 10.0
47 vs 47 (1 yr)
Walsh, 1996
103 100% ADC
Surg +/- RTCT
11.0 vs 16.0
6 vs 32
✔
Bosset, 1997
282 100% SCC
Surg +/- RTCT
18.6 vs 18.6
34 vs 36
Urba, 2001
100 25% SCC 75% ADC
Surg +/- RTCT
17.6 vs 16.9
16 vs 30
Burmeister, 2005 256 37% SCC 63% ADC
Surg +/- RTCT
22.2 vs 19.3
NR
Tepper, 2008
56
25% SCC 75% ADC
Surg +/- RTCT
21.5 vs 53.8
16 vs 39 (5 yrs)
✔
Made with FlippingBook